TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO Share Price
Certificat
DE000SU74DJ5
| Market Closed - Bid/Ask 20:12:34 19/06/2024 BST | ||
| 5.55 EUR | -7.35% |
|
| Current month | -55.63% | ||
| 1 month | -66.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 19/06/24 | 5.55 | -7.35% |
| 18/06/24 | 5.99 | -5.07% |
| 17/06/24 | 6.31 | -9.34% |
| 14/06/24 | 6.96 | +2.20% |
| 13/06/24 | 6.81 | -13.80% |
Real-time Boerse Frankfurt Warrants
Last update June 19, 2024 at 08:12 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU74DJ |
| ISIN | DE000SU74DJ5 |
| Date issued | 09/02/2024 |
| Strike | 950.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 21.36 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.67 € |
|---|---|
| Lowest since issue | 5.3 € |
| Spread | 0.23 € |
| Spread % | 3.90% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
891.5
USD
Average target price
855.4
USD
Spread / Average Target
-4.05%
- Stock Market
- Certificates
- Certificat